RNAC

Cartesian Therapeutics, Inc.

Healthcare · Biotechnology

$219.00 sample

+0.11 (+0.05%) 1D

Market cap

$157.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-21

Alerts

8

Price$219.00 -2.80% 3M daily closessample

230.18215.20

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Chief Executive Officer
Sep 21SEC8-K filed: material event
Sep 16INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: Director
Sep 03INSInsider sell: Chief Financial Officer
Aug 27INSInsider sell: 10% owner
Aug 20SECForm 144 filed
Aug 14INSInsider sell: General Counsel

Sign up to see the real RNAC record →

Company facts

SEC EDGAR registration

Name: Cartesian Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +14sample, -100 to +100
Reporting currency: USD

Who is positioning in RNAC

sample

Insiders: 18 insider transactions over 90 days, net selling, $333.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $2.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.5B +13.6% y/y

Q4 2024Q3 2026

Inventory$2.1B +12.6% y/y

Q4 2024Q3 2026

Accounts receivable$1.6B +13.0% y/y

Q4 2024Q3 2026

Total debt$4.4B +13.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $100.8B -9.7% 3M
Sample peer B: $52.4B -12.2% 3M
Sample peer C: $67.5B +9.0% 3M
Sample peer D: $135.2B +12.4% 3M
Sample peer E: $137.7B -2.0% 3M